Integrative and Quantitative Analysis of Tumor Progression Reveals Fundamental Properties of Glioblastoma
Single-cell RNA-seq · mouse · 152 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 152 samples: 6 conditions, mostly with about 37 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE114456_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA471501 and SRA study SRP147371. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 152 samples.
How we read this: 6 replicated groups read from 152 sample titles; they account for 152 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM3142044 GB1-4 GB1
- GSM3142045 GB1-3 GB1
- GSM3142046 GB1-2 GB1
- GSM3142047 GB1-1 GB1
- GSM3142048 RB1-4 RB1
- GSM3142049 RB1-2 RB1
- GSM3142050 RB1-1 RB1
- GSM3142051 GS2-36 GS2
- GSM3142052 GS2-35 GS2
- GSM3142053 GS2-34 GS2
- GSM3142054 GS2-33 GS2
- GSM3142055 GS2-32 GS2
- GSM3142056 GS2-31 GS2
- GSM3142057 GS2-30 GS2
- GSM3142058 GS2-29 GS2
- GSM3142059 GS2-28 GS2
- GSM3142060 GS2-27 GS2
- GSM3142061 GS2-26 GS2
- GSM3142062 GS2-25 GS2
- GSM3142063 GS2-24 GS2
- GSM3142064 GS2-23 GS2
- GSM3142065 GS2-22 GS2
- GSM3142066 GS2-21 GS2
- GSM3142067 GS2-20 GS2
- GSM3142068 GS2-19 GS2
- GSM3142069 GS2-18 GS2
- GSM3142070 GS2-17 GS2
- GSM3142071 GS2-15 GS2
- GSM3142072 GS2-13 GS2
- GSM3142073 GS2-12 GS2
- GSM3142074 GS2-11 GS2
- GSM3142075 GS2-10 GS2
- GSM3142076 GS2-8 GS2
- GSM3142077 GS2-7 GS2
- GSM3142078 GS2-6 GS2
- GSM3142079 GS2-5 GS2
- GSM3142080 GS2-4 GS2
- GSM3142081 GS2-3 GS2
- GSM3142082 GS2-2 GS2
- GSM3142083 GS2-1 GS2
+ 112 more — browse all 152 samples with per-sample file links →
- GSE261778 Iron oxide nanoparticles inhibit tumor progression and suppress lung metastases in mouse models of breast cancer [RNA-seq] 49 samples shares progression
- GSE244034 Tumor-targeting oncolytic viruses engineered for glioblastoma immunotherapy 48 samples shares glioblastoma
- GSE261845 Targeting melanoma cell-intrinsic beta2 integrin inhibits ICAM-1-mediated tumor progression 20 samples shares progression
- GSE241770 ACSS2 mediates an epigenetic pathway to regulate maternal Beta-cell adaptation and progression of gestational diabetes (scRNA-Seq) 7899 samples shares progression
- GSE311895 Stiffness-related mitochondria transfer promotes tumor progression through metabolic reprogramming 18 samples shares progression
- GSE218013 Anti-CD25 Treg targeting antibodies sparing IL-2 signaling promote regression of established glioblastoma tumors and innate cell activation. 16 samples shares glioblastoma
- GSE308216 A biohybrid chiral hydrogel enhances preclinical postoperative glioblastoma therapy by multi-pronged inhibition of tumor stemness 15 samples shares glioblastoma
- GSE259346 A Private Crosstalk Established by Tumor-Targeted Cytokine Release Rescues CAR-T Activity and Engages Host T Cells against Glioblastoma 12 samples shares glioblastoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.